News
Expansion of the peptide hormone antibody portfolio
August 23 2010
Product launch: Pig NGAL ELISA Kit (KIT 044)
August 12 2010
AACC/Clinical Lab Expo 2010, July 27-29, Anaheim, CA
July 06 2010
IUTOX 2010, July 19-23, Barcelona, Spain
June 30 2010
BioPorto Diagnostics at the ERA-EDTA Congress, Munich, June 25-28
June 14 2010
BioPorto Diagnostics at APCN 2010, June 5-8, Seoul, Korea
May 21 2010
Presentation of The NGAL Test data at the BRS/RA Conference, May 17-20, Manchester, UK
May 14 2010
Product launch: new monoclonal antibodies available
May 07 2010
Presentation of The NGAL Test data at the 30th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
February 22 2010
BioPorto Diagnostics obtains Quality Management Certification
February 18 2010
Expansion of the peptide hormone antibody portfolio
August 23 2010 by BioPorto Diagnostics
BioPorto Diagnostics is pleased to announce the launch of new monoclonal antibodies
The launch of two new anti-ghrelin antibodies provides a tool for measuring total ghrelin levels in human sample. The two antibodies are designed to work together as a sandwich antibody pair to give sensitive measurements.
BioPorto Diagnostics offers an extensive range of monoclonal antibodies within the peptide hormone area. These antibodies are widely used by researchers and pharmaceutical companies around the world. Especially in the field of obesity and type-2 diabetes, these antibodies give researchers a unique opportunity to measure relevant peptide hormones.
